Target intelligence / Profile preview

Adenine bases in single-stranded DNA (ABE7.10 editing window) (ssDNA Adenine (ABE7.10))

Target
ssDNA Adenine (ABE7.10)
Molecular classification
Nucleic acid, Deoxyribonucleic acid (DNA)
01

Overview

Single-stranded DNA adenine bases within the ABE7.10 editing window are the specific molecular targets for Adenine Base Editors (ABEs), which are engineered tools designed for precise genome editing. ABE7.10 is a prominent variant composed of a nickase Cas9 (nCas9) fused to an evolved TadA deoxyadenosine deaminase domain (Gaudelli et al., Nature, 2017). When the CRISPR-Cas9 system targets a specific genomic sequence, it unwinds the DNA double helix, creating a single-stranded DNA loop known as an R-loop. Within a specific "window" of this loop—typically positions 4 through 7 or 8 of the protospacer—the adenine bases become accessible to the deaminase enzyme (Rees & Liu, Nature Reviews Genetics, 2018). The enzyme catalyzes the conversion of adenine to inosine, which the cell's machinery subsequently recognizes as guanine during DNA replication or repair, resulting in a permanent A•T to G•C base pair transition (Kantor et al., Chemical Reviews, 2020). This mechanism allows for the correction of pathogenic point mutations responsible for numerous genetic diseases without the need for double-strand breaks or donor DNA templates. However, the presence of multiple adenines within the window can lead to bystander editing, which remains a significant consideration in therapeutic design.

Other names
A•T to G•C editing siteDeoxyadenosine substrateABE7.10 target siteProtospacer adenine bases
02

Mechanism of action

Hydrolytic deamination of adenine to inosine within the single-stranded DNA bubble created by a CRISPR-Cas9 complex, followed by DNA replication or repair that treats inosine as guanine, resulting in an A-to-G transition.

03

Biological functions

Genetic information storageSubstrate for enzymatic deamination
04

Disease associations

Genetic disorderSickle cell diseaseBeta-thalassemiaCystic fibrosis
05

Safety considerations

Off-target DNA editingBystander editing of non-target adenines within the windowRNA off-target editingImmunogenicity of the Cas9/TadA protein
06

Interacting drugs

Adenine Base Editor 7.10 (ABE7.10)

1 more in the full profile.

07

Biomarkers

Targeted pathogenic single nucleotide polymorphisms (SNPs)A-to-G conversion efficiencyBystander editing frequency

Beyond the preview

Go deeper on Adenine bases in single-stranded DNA (ABE7.10 editing window) (ssDNA Adenine (ABE7.10)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenine bases in single-stranded DNA (ABE7.10 editing window) (ssDNA Adenine (ABE7.10)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call